| Breakdown | TTM | Mar 2025 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.92B | 18.49B | 16.51B | 15.47B | 8.79B | 8.20B |
| Gross Profit | 1.75B | 2.30B | 1.97B | 1.73B | 1.39B | 1.46B |
| EBITDA | 914.50M | 1.26B | 766.00M | 732.00M | 655.00M | 819.00M |
| Net Income | 268.00M | 149.00M | -128.00M | -576.00M | 247.00M | 467.00M |
Balance Sheet | ||||||
| Total Assets | 34.45B | 34.59B | 31.40B | 30.52B | 28.57B | 13.01B |
| Cash, Cash Equivalents and Short-Term Investments | 1.69B | 2.27B | 826.00M | 810.00M | 1.25B | 2.17B |
| Total Debt | 3.89B | 3.52B | 3.70B | 3.69B | 2.93B | 1.64B |
| Total Liabilities | 23.93B | 24.01B | 22.29B | 21.49B | 19.45B | 9.68B |
| Stockholders Equity | 10.42B | 10.46B | 9.00B | 8.91B | 9.04B | 3.27B |
Cash Flow | ||||||
| Free Cash Flow | -427.00M | 490.00M | 175.00M | -1.00B | -720.00M | 202.00M |
| Operating Cash Flow | -58.99M | 972.00M | 606.00M | -577.00M | -455.00M | 476.00M |
| Investing Cash Flow | -371.50M | 123.00M | -478.00M | -443.00M | -1.94B | -368.00M |
| Financing Cash Flow | 147.62M | 244.00M | -61.00M | 558.00M | 1.46B | -1.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $45.34B | 29.34 | 10.94% | 0.46% | 9.59% | 10.69% | |
71 Outperform | $7.02B | 18.22 | 12.47% | 1.41% | 9.77% | 17.13% | |
65 Neutral | $1.52B | 34.09 | 9.51% | 2.71% | -17.66% | -26.36% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | $8.83B | 14.35 | 3.14% | ― | 6.51% | ― | |
55 Neutral | $2.52B | 8.44 | 24.45% | 4.34% | -29.95% | 87.25% | |
54 Neutral | $167.27M | 9.24 | -40.20% | ― | -10.22% | ― |